Genetic Technologies Limited (GENE) has a market capitalization of $111.24M and trades at $0.77. The 52-week range is 0.6666-3.59.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.3, Earnings Per Share (EPS) of $-2.73, annual revenue of $7.66M.
The stock has a beta of 0.48, operates in the Healthcare sector.
